Andrew L. Guggenhime
President & CFOMr. Andrew L. Guggenhime, MBA is Director of Sling Therapeutics, Inc. from January 2025. He serves as Chief Financial Officer at Vaxcyte, Inc., Inc. since May 2020, serves as its President since January 1, 2021, served as its Principal Accounting Officer until January 01, 2023 and served as its Chief Business Officer since May 2020 until January 1, 2021. Mr. Guggenhime serves as an Independent Director at Caribou Biosciences, Inc., since April 2021 and serves as its Independent Chairman. He had been an Independent Director of Metacrine, Inc., since July 2018 until March 23, 2023. Mr. Guggenhime served as Chief Financial Officer at Dermira, Inc. since April 2014 to May 2020 and was its Chief Operating Officer from April 2014 to May 3, 2018. Mr. Guggenhime has Chief Financial Officer Experience. He served as the Chief Financial Officer of CardioDx, Inc. from September 20, 2011 to April 2014. He served as Chief Financial Officer of Calistoga Pharmaceuticals, Inc. since September 2010 to April 2011. He served as the Chief Financial Officer and Senior Vice President of AbbVie Biotherapeutics Inc. (Also known as Facet Biotech Corporation) since December 2008 until June 2010. He served as the Chief Executive Officer and President at AbbVie Biotherapeutics Inc. He served as Senior Vice President and Chief Financial Officer of PDL Biopharma, Inc. from April 3, 2006 to December 18, 2008 and also served as its Principal Accounting Officer until December 18, 2008. He served as Principal Accounting Officer of Facet Biotech Corporation, until July 2007. Mr. Guggenhime served as Chief Financial Officer of Neoforma, Inc. since October 2000 until March 2006 and served as its Company Secretary from June 2002 to March 3, 2006. From January to October 2000, Mr. Guggenhime served as Neoforma Vice President, Corporate Development. He served as Principal Accounting Officer of Neoforma, Inc. He served as the Vice President of Corporate Development, managing Neoforma's corporate development, business development, international and strategic efforts. From August 1996 to January 2000. He served as a Vice President in the Healthcare Investment Banking group of Merrill Lynch & Co., where he specialized in working with healthcare services firms and healthcare Internet companies on a variety of transactions, including mergers and acquisitions, initial public offerings, add-on equity offerings and debt offerings. He served as a Director of CardioDx, Inc. since April 2014 until July 2016. From July 1990 to August 1994, he served in a number of capacities at Wells Fargo & Company, as Assistant Vice President in its Debt Capital Markets group. He served as a Director of Facet Biotech Corporation. Mr. Guggenhime earned a Bachelor of Arts degree in International Politics and Economics from Middlebury College and an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University.
Positions
- Company NameVaxcyte, Inc.Stock CodePCVXPositionPresident & CFOColleagues
- GEGrant E. PickeringCo-Founder, CEO & Director
- CVCarlos V. PayaIndependent Chairman of the Board
- JTJames T. WassilExecutive VP, Chief Scientific Officer & COO
- HSHarpreet S. DhaliwalChief Technical Operations Officer
- JFJeff FairmanCo-Founder & VP of Research
- HEHalley E. GilbertIndependent Director
- ASAnnie Seibold DrapeauIndependent Director
- TLTeri LoxamIndependent Director
- Company NameCaribou Biosciences, Inc.Stock CodeCRBUPositionIndependent ChairmanColleagues
- RERachel E. HaurwitzCo-Founder, CEO, President & Director
- ALAndrew L. GuggenhimeIndependent Chairman
- SRSriram RyaliChief Financial Officer
- BGBarbara G. McClungChief Legal Officer & Corporate Secretary
- JAJennifer A. DoudnaCo-founder & Member of Scientific Advisory Board
- RFRyan FischesserInterim Principal Accounting Officer & Controller
- NSNatalie SacksIndependent Director
- SNScott N. BraunsteinIndependent Director
